These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 28765934
1. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma. Zhou WN, Du YF, Bai J, Song XM, Zheng Y, Yuan H, Zhang W, Zhang ZD, Wu YN. Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934 [Abstract] [Full Text] [Related]
2. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma. Park J, Kim HJ, Kim KR, Lee SK, Kim H, Park KK, Chung WY. Oncotarget; 2017 Feb 07; 8(6):9079-9092. PubMed ID: 28030842 [Abstract] [Full Text] [Related]
3. RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma. Chen F, Bai J, Li W, Mei P, Liu H, Li L, Pan Z, Wu Y, Zheng J. PLoS One; 2013 Feb 07; 8(2):e56241. PubMed ID: 23457532 [Abstract] [Full Text] [Related]
4. Semaphorin 4A restricts tumor progression by inhibiting angiogenesis of oral squamous cell carcinoma cells. Liu XQ, Yao Y, Mu JW, Yang FY. Tissue Cell; 2021 Apr 07; 69():101485. PubMed ID: 33460983 [Abstract] [Full Text] [Related]
5. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9. Wang SS, Zheng M, Pang X, Zhang M, Yu XH, Wu JB, Gao XL, Wu JS, Yang X, Tang YJ, Tang YL, Liang XH. Mol Carcinog; 2019 Oct 07; 58(10):1809-1821. PubMed ID: 31219646 [Abstract] [Full Text] [Related]
6. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells. Dai J, Wei W. Arch Oral Biol; 2017 Nov 07; 83():40-46. PubMed ID: 28697409 [Abstract] [Full Text] [Related]
7. Effect and mechanism of RUNX3 gene on biological characteristics of human esophageal squamous cell carcinoma (ESCC). Chen H, Wang Z, Wang S, Zhang Z, Shi S. Med Oncol; 2015 Jan 07; 32(1):357. PubMed ID: 25428380 [Abstract] [Full Text] [Related]
8. Trks are novel oncogenes involved in the induction of neovascularization, tumor progression, and nodal metastasis in oral squamous cell carcinoma. Sasahira T, Ueda N, Yamamoto K, Bhawal UK, Kurihara M, Kirita T, Kuniyasu H. Clin Exp Metastasis; 2013 Feb 07; 30(2):165-76. PubMed ID: 22886570 [Abstract] [Full Text] [Related]
9. RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer. Kim BR, Kang MH, Kim JL, Na YJ, Park SH, Lee SI, Kang S, Joung SY, Lee SY, Lee DH, Min BW, Oh SC. Oncol Rep; 2016 Nov 07; 36(5):2601-2608. PubMed ID: 27633042 [Abstract] [Full Text] [Related]
10. Overexpression of RUNX3 inhibits malignant behaviour of Eca109 cells in vitro and vivo. Chen HX, Wang S, Wang Z, Zhang ZP, Shi SS. Asian Pac J Cancer Prev; 2014 Nov 07; 15(4):1531-7. PubMed ID: 24641363 [Abstract] [Full Text] [Related]
11. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Li C, Li Q, Cai Y, He Y, Lan X, Wang W, Liu J, Wang S, Zhu G, Fan J, Zhou Y, Sun R. Cancer Gene Ther; 2016 Sep 07; 23(9):295-302. PubMed ID: 27492854 [Abstract] [Full Text] [Related]
12. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells. Lin CC, Chen PC, Lein MY, Tsao CW, Huang CC, Wang SW, Tang CH, Tung KC. Oncotarget; 2016 Mar 01; 7(9):9993-10005. PubMed ID: 26824419 [Abstract] [Full Text] [Related]
13. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. Lin CS, Lin YC, Adebayo BO, Wu A, Chen JH, Peng YJ, Cheng MF, Lee WH, Hsiao M, Chao TY, Yeh CT. Cancer Lett; 2015 Nov 01; 368(1):36-45. PubMed ID: 26184998 [Abstract] [Full Text] [Related]
15. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation. Zhao X, Liu D, Wang L, Wu R, Zeng X, Dan H, Ji N, Jiang L, Zhou Y, Chen Q. J Oral Pathol Med; 2016 Apr 10; 45(4):256-61. PubMed ID: 26449957 [Abstract] [Full Text] [Related]
16. Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer. Chen F, Wang M, Bai J, Liu Q, Xi Y, Li W, Zheng J. PLoS One; 2014 Apr 10; 9(1):e86917. PubMed ID: 24475196 [Abstract] [Full Text] [Related]
17. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway. Wang H, Wang L, Zhou X, Luo X, Liu K, Jiang E, Chen Y, Shao Z, Shang Z. Biomed Res Int; 2020 Apr 10; 2020():2125656. PubMed ID: 32695810 [Abstract] [Full Text] [Related]
18. MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression. Nagai H, Hasegawa S, Uchida F, Terabe T, Ishibashi Kanno N, Kato K, Yamagata K, Sakai S, Kawashiri S, Sato H, Yanagawa T, Bukawa H. Int J Oncol; 2018 Mar 10; 52(3):841-850. PubMed ID: 29393341 [Abstract] [Full Text] [Related]
19. Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis. Lin CW, Yang WE, Lee WJ, Hua KT, Hsieh FK, Hsiao M, Chen CC, Chow JM, Chen MK, Yang SF, Chien MH. Carcinogenesis; 2016 Jul 10; 37(7):712-722. PubMed ID: 27207653 [Abstract] [Full Text] [Related]
20. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis. Jili S, Eryong L, Lijuan L, Chao Z. Cell Biochem Funct; 2016 Dec 10; 34(8):597-605. PubMed ID: 27859417 [Abstract] [Full Text] [Related] Page: [Next] [New Search]